Developing a Model of Care for Home Infusions of Natalizumab for People With Multiple Sclerosis

Natalizumab is an effective treatment for multiple sclerosis that requires 4-weekly infusions that are usually provided in hospital outpatient clinics. In this study, a model of care (MOC), an overarching design for the provision of a health care service, was developed to permit home infusions of natalizumab. The proposed new MOC comprised 9 dimensions, in addition to the central concept of patient-centered care at home. The new MOC is responsive to patient needs and prioritizes the nurse–patient therapeutic relationship. It provides practical examples of patient-centered care to guide clinical practice for this patient population in the home setting.